For the reason that launch of the partnership in February 2024, Pfizer has acquired functions from over 200 start-ups throughout the nation specializing in options for well timed screening and cost-effective diagnostic instruments.
The shortlisting standards to resolve the ultimate six included the potential influence of the product or resolution, degree of technological innovation, uniqueness of the worth proposition, aggressive benefit, monetary and operational scalability, and readability on the longer term roadmap.
The profitable start-ups will obtain a grant of Rs 25 lakhs every from Pfizer, whereas NIPER-Ahmedabad will present complete incubation help that can assist speed up their lab-to-market journey.
The winners embody Aarca Analysis, Babycue Pvt Ltd, Biolockey Healthworks Pvt Ltd, Brela Improvements Pvt Ltd, RNT Well being Insights Pvt Ltd and Utopic Tech Pvt Ltd.
Dr. Arunish Chawla, secretary DoP introduced that below the PRIP (Promotion of Analysis and Innovation in Pharma-MedTech) scheme or Analysis Linked Incentive Scheme these 6 startups would be the first set of winners to safe funding. They’re additionally authorized for help for pre-clinical and medical research.
Uncover the tales of your curiosity
“With grants from Pfizer and incubation help from our program companions, I’m assured that these start-ups will get the total help to quickly carry their groundbreaking concepts to the market and ship the promise of constructing a major distinction in healthcare supply in our nation,” stated Meenakshi Nevatia, MD of Pfizer Ltd, stated.
Discover more from News Journals
Subscribe to get the latest posts sent to your email.
